Trilinolein-d5

Trilinolein-d5 is a deuterium-labeled form of Trilinolein. Trilinolein is an orally active triglyceride that targets and inhibits the PI3K/Akt, Ras/MEK/ERK signaling pathways, as well as MMP-2. It mitigates oxidative stress, induces apoptosis, and inhibits cell migration. Trilinolein is utilized in research related to cardiovascular diseases, cerebrovascular conditions (such as cerebral ischemia), and non-small cell lung cancer.